<--GAT-->
Clinical Topics

Some RCC Risk Factors Can Be Modified

by U.S. Medicine

January 1, 2019

SAN ANTONIO—Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study.

A study team from the University of Texas Health Science Center and the South Texas Veterans Healthcare System sought to determine what those are to target disease prevention and reduce healthcare costs.

For an analysis in the journal Urologic Oncology, the researchers used data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, looking at the primary outcome of kidney cancer and focusing on demographics and modifiable risk factors.1

PLCO is a large population-based randomized trial designed and sponsored by the National Cancer Institute to determine the effects of screening on cancer-related mortality and secondary endpoints in men and women aged 55 to 74. The screening component of the trial was completed in 2006, with participants followed and additional data collected through 2015. 

After missing data were excluded, the researchers analyzed 149,683 participants, noting that 0.5% developed renal cancer. Significantly associated with renal cancer in bivariate analysis (P<0.05) was age, male gender, body mass index, diabetes and hypertension, according to the study team, which added that men have a significant increased risk of kidney cancer over women (hazard ratio [HR] = 1.85; 95% CI: 1.58-2.16; P<0.0001).

Age was identified as a nonmodifiable risk factors associated with kidney

(HR = 1.05; 95% CI: 1.01; 1.05, P = 0.001). Modifiable risk factors include:

  • Obesity measured by body mass index (HR = 1.05; 95% CI: 1.02-1.07; P<0.0001),
  • Hypertension (HR = 1.32; 95% CI: 1.13-1.54; P = 0.0004), and
  • Smoking in pack-years (HR = 1.04; 95% CI: 1.02-1.07; P = 0.0002).

1. Gelfond J, Al-Bayati O, Kabra A, Iffrig K, Kaushik D, Liss MA. Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial. Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17. PubMed PMID: 29779672.



Related Articles

Physician Documents, Promotes Veteran Honor Guards in VA Hospices

PHILADELPHIA—Michelle Brassil, MD, had been warned when she began her fellowship at the Cpl. Michael J. Crescenz VA Medical Center’s Community Living Center in Philadelphia. “Don’t be surprised if you’re emotional,” her supervisor told her.... View Article

Lack of DoD/VA Decision-Maker Could Hamper EHR Implementation

WASHINGTON—Plans are moving ahead for VA’s 10-year, $16 billion effort to modernize its electronic health record system, but legislators still have questions about the project’s timeline and funding, as well as concerns about the project’s... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Surgical Staging Often Inadequate for Gallbladder Cancer

Guidelines frequently aren’t followed when it comes to radical cholecystectomy with regional lymphadenectomy for patients with T1b gallbladder cancer.

Oncology

Use of Hospice During Treatment Has Limited VA Use

Unlike in most private sector settings, veterans with advanced cancer can receive hospice care concurrently with treatments such as radiation and chemotherapy.

Oncology

Hypertension, MGUS Associated with Herbicide Exposure in Vietnam Veterans

Based on a new review, two conditions–one extremely common and the other rare–appear to be related to herbicide exposure during the Vietnam War era.

Oncology

Detailed Medical History Crucial for Lung Disease Diagnosis

Both general medicine physicians and specialists can find interstitial lung disease (ILD) and pulmonary fibrosis confusing, according to a recent study.

Oncology

Melanomas Associated With Internal Malignancy Risk

Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPM) but a new study questioned whether those patients might have increased predisposition to developing internal malignancies.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up